Title:
HYALURONIC ACID-LIPID DERIVATIVE, LIPID NANOPARTICLE COMPRISING SAME, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/282652
Kind Code:
A2
Abstract:
The present invention relates to a hyaluronic acid-lipid derivative, lipid nanoparticles comprising same, and a use thereof. The lipid nanoparticles comprising the hyaluronic acid-lipid derivative according to the present invention can be utilized as a vaccine or a drug delivery carrier for effectively carrying mRNA, proteins, and other drugs and stably delivering same into the body, and such a vaccine or drug delivery carrier has excellent mucoadhesive properties and mucosal permeability and thus has the advantage of enabling vaccine or drug delivery via the nasal cavity and lungs.
Inventors:
HAHN SEI KWANG (KR)
SUNG YOUNG CHUL (KR)
JEONG DAHAM (KR)
KIM MUN GU (KR)
KIM HWAN HEE (KR)
SUNG YOUNG CHUL (KR)
JEONG DAHAM (KR)
KIM MUN GU (KR)
KIM HWAN HEE (KR)
Application Number:
PCT/KR2022/009827
Publication Date:
January 12, 2023
Filing Date:
July 07, 2022
Export Citation:
Assignee:
GENEXINE INC (KR)
PHI BIOMED INC (KR)
POSTECH RES & BUSINESS DEV FOUND (KR)
PHI BIOMED INC (KR)
POSTECH RES & BUSINESS DEV FOUND (KR)
International Classes:
A61K39/215
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: